Screener
Collegium Pharmaceutical, Inc. COLL Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 106,594 | 73,279 | 192,944 | 148,916 |
| Income from operations | 3,698 | 35,105 | 34,594 | 56,792 |
| Interest expense | (19,519) | (20,463) | (35,381) | (41,253) |
| Interest income | 2,289 | 2,383 | 5,995 | 4,608 |
| (Loss) income before income taxes | (13,532) | 17,025 | 5,208 | 20,147 |
| Provision for income taxes | 1,519 | 5,042 | 5,763 | 5,747 |
| Net (loss) income | $(15,051) | $11,983 | $(555) | $14,400 |
| (Loss) earnings per share — basic | $(0.46) | $0.38 | $(0.02) | $0.45 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s interest income?
- Collegium Pharmaceutical, Inc. (COLL) reported interest income of $2.29M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s interest income changed year-over-year?
- Collegium Pharmaceutical, Inc.'s interest income decreased by 3.9% year-over-year, from $2.38M to $2.29M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s interest income?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s interest income has grown at a 453.8% compound annual growth rate (CAGR), from $12K to $11.29M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Collegium Pharmaceutical, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude